Home βΊ Calculator βΊ PACB Dividend Calculator 2026
PACB Dividend DRIP Calculator 2026
155.04% YieldHealthcarePacific Biosciences of California, Inc. Β· NASDAQ
Price: $1.29 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
π‘ What-if scenarios
Click to apply scenario to the calculator
π― When PACB pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your PACB snowball π
$10,000 in PACB β $116.43M in 10 years Β· $5,898,135.26/month
About Pacific Biosciences of California, Inc. (PACB) β Dividend Analysis 2026
Pacific Biosciences of California, Inc. (PACB) specializes in pioneering and manufacturing advanced genetic sequencing platforms, empowering researchers and institutions to unravel intricate genetic challenges. At the heart of its offerings are the proprietary PacBio Sequencing Systems, designed for executing, monitoring, and interpreting biochemical sequencing reactions. Complementing these instruments are essential consumable products, such as their unique single molecule real-time (SMRT) cells. Furthermore, the company supplies a comprehensive suite of workflow-specific reagent kits. These include template preparation kits, which utilize molecular biology reagents (like ligase, buffers, and exonucleases) to convert DNA into SMRTbell double-stranded DNA libraries. Binding kits, featuring modified DNA polymerase, facilitate the crucial attachment of SMRTbell libraries to the polymerase in readiness for sequencing. Finally, specialized sequencing kits contain all necessary reagents, including phospholinked nucleotides, for real-time sequencing directly on their instruments. Pacific Biosciences caters to a broad global clientele, encompassing prominent research institutions, commercial diagnostic laboratories, large-scale genome centers, public health organizations, hospitals, clinical research institutes, contract research organizations (CROs), academic bodies, pharmaceutical firms, and agricultural enterprises. Product commercialization is managed through a direct sales force across North America and Europe, complemented by a robust network of distribution partners spanning Asia, the Middle East, Africa, and Latin America. A significant strategic alliance includes a development and commercialization agreement with Invitae Corporation. Originally incorporated in 2000 as Nanofluidics, Inc., the company adopted its current name, Pacific Biosciences of California, Inc., in 2005. Its corporate headquarters are situated in Menlo Park, California.
Compare PACB with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full PACB DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open PACB position with:
π PACB Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold PACB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 155.04% | 152.24% | $15,504 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 131.78% | 128.98% | $13,178 / yr |
| πΊπΈ US Taxable (20%) | 20% | 124.03% | 121.23% | $12,403 / yr |
| π¬π§ UK ISA | 0% | 155.04% | 152.24% | $15,504 / yr |
| π¬π§ UK Taxable | 8.75% | 141.47% | 138.67% | $14,147 / yr |
| π¨π¦ TFSA | 0% | 155.04% | 152.24% | $15,504 / yr |
| π¨π¦ CA Taxable | 25% | 116.28% | 113.48% | $11,628 / yr |
| π¦πΊ Super (pension) | 15% | 131.78% | 128.98% | $13,178 / yr |
| π¦πΊ AU Taxable | 30% | 108.53% | 105.73% | $10,853 / yr |
| π©πͺ DE Taxable | 26.375% | 114.15% | 111.35% | $11,415 / yr |
| π«π· FR Taxable | 30% | 108.53% | 105.73% | $10,853 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
π― PACB Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
π PACB Dividend Payment Schedule
PACB pays quarterly β 4 times per year. Next ex-div: TBD.
π PACB vs Healthcare Benchmarks
How PACB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PACB sourced from FMP /financial-growth endpoint β real data, not estimates.
ποΈ PACB Insider Activity
No recent SEC filings reported in the last 90 days.Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where PACB earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PACB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Pacific Biosciences of California, Inc. (PACB) is currently trading at $1.29, 96% below its 52-week high. The current dividend yield is 155.04% based on an annual payout of $2.00 per share.
PACB (Pacific Biosciences of California, Inc.) β 155.04% Dividend Yield Analysis
Pacific Biosciences of California, Inc. (PACB) is a healthcare stock currently trading at $1.29 with a dividend yield of 155.04%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (155.04%) may signal elevated risk β verify sustainability.
Auto-generated from live market data. For educational purposes only β not financial advice.